Congratulations to BoardProspects Member Ron Squarer on His Appointment to the Board of Retrophin (NASDAQ: RTRX)
BoardProspects would like to congratulate its member Ron Squarer on his recent appointment to the Board of Directors of Retrophin, Inc. (NASDAQ: RTRX). Mr. Squarer is chief executive officer and a director of Array BioPharma Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule therapies.
Retrophin is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.
Login to comment.